50% off Premium Yearly
US Fed's Jerome Powell has signified he will start to cut interest rates and he's very dependent on data. There's a slowdown in labour demand, but the borders are shut to prevent new labour from entering. Super-core CPI is Powell's key indicator, at 3.2% now. But there are many people on the Fed board and some fracturing of opinion. It's possible a new Fed chair will be more malleable to the president, but he frets over that.
After Jerome Powell's remarks last Friday, stocks ripped, but not bonds. We didn't learn much from his speech, except that September is on the table. Futures indicate 5 rate cuts from now to the end of 2026. He expects Powell to cut 0.25% in September with the market pricing that by 80-85%. It was slightly less than before Powell spoke. Canadian futures indicate 1 more 0.25% cut by mid-2026. Therefore, the US will cut more aggressively and catch up to Canada. Canada is way structurally weaker than the US, and the CAD lacks a catalyst to rally. Normally, the CAD would rally a lot. Maybe the CAD reaches 75 cents, unless there is a rocky Sept-Oct and trade negotiations get rocky. Those with lots of USD exposure in ETFs should consider moving that into a hedged version should the CAD drift to 70 cents in the next few months.
Dumping a high-growth tech stock then planning to buy back at a lower price is a lot harder than you think. He sold GOOG after the Justice Dept. called GOOG a monopolist. Then, GOOG went up and the Justice Dept. did not break up GOOG. He didn't get back into the stock. In fact, GOOG is worth more if it is broken up into separate companies. He has tremendous remorse over selling it. Lesson: trading is the enemy of many investors.
Sure, there are concerns including their demand in China, and will the hyperscalers cut back on buying NVDA chips? You can't have gen-AI without NVDA chips. The new NVDA chips allow chatbots to reason--reasoning will be the holy grail of the AI generation. Selling ahead of this week's report is wrong.
They just reported revenues a little light and EPS also missed, basically was flat YOY, but the quarter was still good. The misses were partly based on poor weather last quarter (a wet spring). Same-stores sales over the quarter locked flat, but was +3.1% in July after two flat months. Management is confident in its distribution centres and reiterated its full-year forecast. If interest rates fall (looking likely), it will only help the housing and home improvement market. The tariff hit will be minimized because many HD products are made in the US.
Was down 43% in 2024, led by their managed care business, to be one of the worst stocks of 2024. But that business is now finally turning around, +12% in revenues in Q2 YOY, and revenues beating the street. So, the health insurance side is doing much better. They raised revenue guidance and full-year earnings. Firing on nearly all cylinders: drug store, pharmacy benefits, health service division (including in-store medical clinics) saw 10.2% revenue growth. Also, the front-of-store and pharmacy delivered a strong revenue beat and growing 12.5% YOY as competitors have vanished (i.e. RiteAid). Pharmacy sales were +18% YOY. CVS shares are up 58% this year and trades at only 11x PE and pays a 3.7% dividend. The CEO has done a remarkable job this year. Has more room to run.
They report later this week. In some ways, they will hit it out of the park, but how much sentiment is built into the stock already? NVDA has had a huge run, doubling since April. He suspects some people are over-invested and few who are under-invested. No, he won't buy it ahead of earnings, unless you're a daytrader looking at options.